My priority in this role is to work personally to ensure that patients in Switzerland have the fastest possible access to innovative therapies. I am also committed to ensuring that Switzerland remains a highly attractive location for the life science industry in the future – in research & development, production, but also as a location for international headquarters.
We are fortunate to have a location where universities, start-ups, global companies and leading hospitals work closely together – to the benefit of patients. I see a need to catch up in digitalization of the healthcare system – Switzerland is clearly lagging behind in this area, ultimately to the detriment of the population and research. We at Interpharma are working on concrete proposals for solutions and are ready to actively cooperate in their implementation – together with all players in the healthcare sector.
Health and sustainability are two inseparable topics. That is why sustainability is a fundamental part of Johnson & Johnson’s efforts. In Switzerland, we have partnered with a leading hospital group to implement a recycling project that returns valuable materials from operating rooms to the resource cycle. Another example is “Safe Returns”, where patients suffering from psoriasis or Crohn’s disease simply put their injection syringes in a bag in their own mailbox, the post office collects the bag and we recycle the syringes at our plant in Schaffhausen.
Member of the Executive Board / Head of Communications
+41 61 264 34 85
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2020
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives